Literature DB >> 954232

Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.

A Z Lurhuma, C L Cambiaso, P L Masson, J F Heremans.   

Abstract

The agglutination of Ig-coated particles by human RF or Clq can be inhibited by Ig aggregates or AgAb complexes. The effect of Ig class was studied by means of agarose-linked human monoclonal Igs. RF was inhibited by all subclasses of IgG and IgA but not by IgM, whereas Clq reacted with IgM, IgG3 and IgG1. Heat-aggregated IgG3 was fractionated by gel-filtration on Ultrogel. Inhibition was restricted to certain fractions of aggregates, viz (IgG3) approximately 7 and (IgG3) approximately 21 for RF, and (IgG3) approximately 10, (IgG3) approximately 14 and (IgG3) approximately 27 for Clq. In a precipitin curve experiment, it was found that RF was inhibited by soluble complexes over an extended range of AgAb ratios, the inactivation of Clq being limited to complexes with 2-5 times antigen excess. Inhibiting factors were found in patients with various diseases and, at low titres, in 22% of healthy people. In 27% of patients' sera, the inhibitors were demonstrable by Clq only after removal of endogenous RF by adsorption on insolubilized IgG. In several patients endogenous agglutinating activity and direct inhibitory activity tended to alternate during the course of the disease. Sera from various patients were also filtrated on Ultrogel and the elution was monitored by immunoassay of IgA, IgM and IgG, as well as by the two inhibition tests. The inhibiting factors were distributed over several peaks which only partially coincided with the elution profiles of IgG and IgM.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954232      PMCID: PMC1541367     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  ANTI-BOVINE SERUM ALBUMIN AND ANTI-ALPHA LACTALBUMIN IN THE SERUM OF CHILDREN AND ADULTS.

Authors:  R M ROTHBERG; R S FARR
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

2.  Antibodies to rabbit gamma-globulin after immunizing with various preparations of autologous gamma-globulin.

Authors:  R C WILLIAMS; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1963-03

3.  Reduced red cell survival in jaundice and its relation to abnormal glutathione metabolism.

Authors:  C S PITCHER; R WILLIAMS
Journal:  Clin Sci       Date:  1963-04       Impact factor: 6.124

4.  Isolation of a thermolabile serum protein which precipitates gamma-globulin aggregates and participates in immune hemolysis.

Authors:  H J MULLER-EBERHARD; H G KUNKEL
Journal:  Proc Soc Exp Biol Med       Date:  1961-02

5.  Precipitating factor for aggregated gamma-globulins in normal human sera.

Authors:  A TARANTA; H S WEISS; E C FRANKLIN
Journal:  Nature       Date:  1961-01-21       Impact factor: 49.962

6.  Gamma globulin complexes in rheumatoid arthritis and certain other conditions.

Authors:  H G KUNKEL; H J MULLER-EBERHARD; H H FUDENBERG; T B TOMASI
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

7.  Agglutination of erythrocytes coated with incomplete anti-Rh by certain rheumatoid arthritic sera and some other sera; the existence of human serum groups.

Authors:  R GRUBB
Journal:  Acta Pathol Microbiol Scand       Date:  1956

8.  Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes.

Authors:  T Ishizaka; K Ishizaka; S Salmon; H Fudenberg
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

9.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

10.  Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera.

Authors:  A N Theofilopoulos; C B Wilson; V A Bokisch; F J Dixon
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  36 in total

1.  Human serum inhibits the interaction between C1q or rheumatoid factor and IgG-coated latex particles. Reduction of these C1-dependent properties after complement activation in vitro and in vivo.

Authors:  R Hällgren
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

2.  Rat spleen leucocyte (RSL) radioimmunoassay for the detection and quantification of soluble immune complexes.

Authors:  S F Al-Khateeb; T Barkas
Journal:  Clin Exp Immunol       Date:  1978-12       Impact factor: 4.330

3.  Polymorphonuclear leucocytes in Crohn's disease and ulcerative proctocolitis: association between enhanced adherence to nylon fibre and disease variables.

Authors:  J Cason; C C Ainley; R A Wolstencroft; R P Thompson
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  Circulating immune complexes and disease activity in Crohn's disease.

Authors:  R Fiasse; A Z Lurhuma; C L Cambiaso; P L Masson; C Dive
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

5.  Circulating immune complexes in serum from patients with dengue haemorrhagic fever.

Authors:  W Ruangjirachuporn; S Boonpucknavig; S Nimmanitya
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

6.  Circulating immune complexes in normal pregnant women and in some conditions complicating pregnancy.

Authors:  R D'Amelio; P Bilotta; A Pachì; F Aiuti
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

7.  Surgical and immunological aspects of Takayasu's disease.

Authors:  S Gupta
Journal:  Ann R Coll Surg Engl       Date:  1981-09       Impact factor: 1.891

8.  Immunological studies in typhoid fever. I. Immunoglobulins, C3, antibodies, rheumatoid factor and circulating immune complexes in patients with typhoid fever.

Authors:  P Rajagopalan; R Kumar; A N Malaviya
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

9.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

10.  The binding of myelin basic protein to the Fc region of aggregated IgG and to immune complexes.

Authors:  C J Sindic; C L Cambiaso; P L Masson; E C Laterre
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.